Results for tag: "Radioimmunoassay"

Radioimmunoassay (RIA) is a laboratory technique used to measure the concentration of antigens, such as hormones, in a sample. In the context of oncology drugs, RIA is used to measure the concentration of tumor markers in the blood, which can help diagnose and monitor cancer. RIA can also be used to measure the concentration of therapeutic drugs in the blood, which can help determine the effectiveness of a drug and its dosage. RIA is a highly sensitive and specific technique, and is used in many clinical laboratories. It is also used in research laboratories to study the pharmacokinetics of drugs, and to develop new drugs. In the oncology drug market, RIA is used to measure the concentration of therapeutic drugs in the blood, and to monitor the effectiveness of the drug. It is also used to measure the concentration of tumor markers in the blood, which can help diagnose and monitor cancer. Some companies in the RIA market for oncology drugs include Abbott Laboratories, Beckman Coulter, Siemens Healthcare, and Roche Diagnostics. Show Less Read more